GLMD and GPH Related Headlines
Go Back- Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
- Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro
GLMD and GPH Related Press Releases
Go Back- Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
- Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro
